A collection of news and information related to Orexigen Therapeutics, Inc. published by this site and its partners.
Top Orexigen Therapeutics, Inc. Articles see all
Displaying items 1-1
Story | Nov 27, 2013 | 3:47 PMThe makers of the proposed weight-loss drug Contrave said this week they have taken a key first step in showing that the medication does not boost the heart and stroke risks of those taking it, and they announced plans to return to the Food and Drug Administration to seek its approval in the coming weeks.